Pulmonary Embolism
Pulmonary Embolism
Blockage of pulmonary arteries by thrombus, fat or air embolus, or tumor tissue
Obstructs alveolar perfusion
Most commonly affects lower lobes
Picture 1
Picture 2
Risk factors -Deep vein thrombosis (90%) -Immobility or reduced mobility -Surgery -History of DVT -Malignancy -Obesity -Oral contraceptives/ hormones -Smoking -Heart failure -Pregnancy/delivery -Clotting disorders -Atrial fibrillation -Central venous catheters -Fractured long bone
Clinical Manifestations
Signs and symptoms: -Dyspnea ,Tachypnea -Cough, chest pain -Hemoptysis, Crackles -Wheezing -Fever, tachycardia, -Syncope, change in LOC
The signs and symptoms in PE are varied and nonspecific, making diagnosis difficult. Symptoms may
begin slowly or suddenly.
Dyspnea is the most common presenting symptom, occurring in 85% of patients with PE.
A mild to moderate hypoxemia with a low PaCO2 is a common finding.
Other manifestations are: -tachypnea, -cough, -chest pain, -hemoptysis, -crackles, -wheezing, -fever, -tachycardia, -syncope, and -sudden change in mental status as a result of hypoxemia. -Can also cause accentuation of pulmonic heart sound.
Clinical manifestations are dependent on the size and extent of emboli. Massive emboli may produce
abrupt hypotension and shock. The mortality rate for massive PE is 30-60%, with most deaths occurring
within 1-2 hours of onset.
Conversely, small emboli may go undetected or produce vague, transient symptoms. The exception to
this is the patient with underlying cardiopulmonary disease. In these patients, even small or medium
sized emboli may result in severe cardiopulmonary compromise.
Repeated pulmonary emboli gradually cause a reduction in the capillary bed and eventual pulmonary
hypertension. Right ventricular hypertrophy can develop secondary to pulmonary hypertension.
Diagnostic Studies
D-Dimer
Spiral (helical) CT scan - "CT PE protocol"
Ventilation - Perfusion (V/Q) scan
Pulmonary Angiogram
Arterial blood gases (ABGs)
Complications: Pulmonary infarction -Alveolar necrosis and hemorrhage -Abscess -Pleural effusion
Pulmonary infarction (death of lung tissue) is most likely when the following factors are present:
(1) occlusion of a large or medium-sized pulmonary vessel (2 mm in diameter),
(2) insufficient collateral blood flow from the bronchial circulation, or
(3) preexisting lung disease.
Infarction results in alveolar necrosis and hemorrhage.
Occasionally the necrotic tissue becomes infected, and an abscess may develop.
Concomitant pleural effusion is frequent.
Complications: Pulmonary hypertension
Results from hypoxemia associated with massive or recurrent emboli
Right ventricular hypertrophy
Pulmonary hypertension results from hypoxemia or from involvement of more than 50% of the area of
the normal pulmonary bed. As a single event, an embolus does not cause pulmonary hypertension
unless it is massive. -Recurrent emboli may result in chronic pulmonary hypertension. -Pulmonary hypertension eventually results in dilation and hypertrophy of the right ventricle. -Depending on the degree of pulmonary hypertension and its rate of development, outcomes can vary,
with some patients dying within months of the diagnosis and others living for decades.
Collab Care: Goals of treatment
Prevent further thrombi
Prevent further embolization to pulmonary system
Content preview
Pulmonary Embolism
Pulmonary Embolism
Blockage of pulmonary arteries by thrombus, fat or air embolus, or tumor tissue
Obstructs alveolar perfusion
Most commonly affects lower lobes
Picture 1
Picture 2
Risk factors
-Deep vein thrombosis (90%)
-Immobility or reduced mobility
-Surgery
-History of DVT
-Malignancy
-Obesity
-Oral contraceptives/ hormones
-Smoking
-Heart failure
-Pregnancy/delivery
-Clotting disorders
-Atrial fibrillation
-Central venous catheters
-Fractured long bone